4.3 Review

A systematic review and meta-analysis of thoracoscopic versus thoracotomy sleeve lobectomy

期刊

JOURNAL OF THORACIC DISEASE
卷 12, 期 10, 页码 5678-+

出版社

AME PUBLISHING COMPANY
DOI: 10.21037/jtd-20-1855

关键词

Video-assisted thoracoscopic surgery (VATS); robotic-assisted thoracoscopic surgery (RATS); thoracotomy; sleeve lobectomy; non-small cell lung cancer (NSCLC)

资金

  1. Clinical Research Foundation of Shanghai Pulmonary Hospital [FK1943, FK1936, FK1942, FK1941]
  2. Shanghai Municipal Health Commission [2018ZHYL0102, 2019SY072]
  3. Medicine and Public Health Scientific Projects in Zhejiang Province [2020KY270]
  4. Huamei Key Research Foundation [2019HMZD05]

向作者/读者索取更多资源

Background: Operative safety and oncologic adequacy of thoracoscopic sleeve lobectomy remain controversial. As such, the purpose of this meta-analysis was to evaluate evidence comparing thoracoscopy and thoracotomy in sleeve lobectomy for centrally located non-small cell lung cancer (NSCLC). Methods: Electronic searches of PubMed and Web of Science databases were undertaken from inception to March 2020. Comparative studies about thoracoscopic and thoracotomy sleeve lobectomy, with evaluation for perioperative outcomes and oncological results were identified. The following outcomes were measured in this meta-analysis: operating time, blood loss, numbers of lymph node, postoperative hospital stay, chest drainage time, postoperative complication rate, mortality, overall survival (OS). The standardized difference (SMD), relative risk (RR) and hazard ratio (HR) with 95% confidence intervals (CI) were pooled using Stata software. Results: Six studies generating 281 thoracoscopy and 369 thoracotomy cases were finally included. There was no significant difference in intraoperative blood loss, number of resected lymph nodes, chest drainage time, postoperative complication rate and mortality between two groups. However, thoracoscopic sleeve lobectomy was associated with longer operation time (SMD 0.59, 95% CI: 0.14 to 1.03, P=0.010). And shorter postoperative hospital stays (SMD -0.24, 95% CI: -0.51 to 0.03, P=0.078) were observed in the thoracoscopy group with marginal significance. Furthermore, sleeve lobectomy via thoracoscopy could achieve comparable OS compared to that via thoracotomy (HR 0.69, 95% CI: 0.38 to 1.00; P<0.001). In addition, there were no evident publication bias in all observational outcomes. Conclusions: Current evidence suggests that thoracoscopic sleeve lobectomy is a safe and efficient surgical procedure for centrally located NSCLC, with comparable perioperative outcomes and equivalent oncological results compared to thoracotomy sleeve lobectomy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据